FMP

FMP

Enter

COO - The Cooper Companies...

Financial Summary of The Cooper Companies, Inc.(COO), The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets cont

photo-url-https://financialmodelingprep.com/image-stock/COO.png

The Cooper Companies, Inc.

COO

NASDAQ

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

90.52 USD

0.11 (0.122%)

About

ceo

Mr. Albert G. White III

sector

Healthcare

industry

Medical - Instruments & Supplies

website

https://www.coopercos.com

exchange

NASDAQ

Description

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and pat...

CIK

0000711404

ISIN

US2166485019

CUSIP

216648402

Address

6101 Bollinger Canyon Road

Phone

925 460 3600

Country

US

Employee

15,000

IPO Date

Jan 21, 1983

Summary

CIK

0000711404

Exchange

NASDAQ

Industry

Medical - Instrument...

Sector

Healthcare

CUSIP

216648402

ISIN

US2166485019

Country

US

Price

90.52

Beta

0.95

Volume Avg.

1.13M

Market Cap

17.99B

Shares

-

52-Week

75.935-104.07

DCF

38.24

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

62

P/B

-

Website

https://www.coopercos.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest COO News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep